Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers
Clinical trial NCT05124730 · COMPLETED
Trial details
- NCT number
- NCT05124730
- Sponsor
- Joint Stock Company "Farmak"
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-21
- Primary completion
- 2021-05-29
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.